THERAMEX
20.3.2023 17:29:26 CET | Business Wire | Press release
Theramex, a leading global speciality pharmaceutical company dedicated to women’s health, has entered into an exclusive licensing agreement with Radius Health, Inc., for the rights to commercialise ELADYNOS® (abaloparatide), a novel bone forming agent indicated for the treatment of osteoporosis in postmenopausal women at increased risk of fractures.
Theramex will commercialise and distribute ELADYNOS® on an exclusive basis in the European Economic Area, the United Kingdom, Australia and Brazil.
“Theramex has again shown its commitment to women and the care and good management of bone health, by adding this important product to our Osteoporosis franchise. We are delighted to be entering into this partnership with Radius, building on our expanding portfolio and aligning missions to reduce fracture risks for many postmenopausal women suffering from osteoporosis.” - Rob Stewart, CEO of Theramex
“We are thrilled to have Theramex bring abaloparatide to postmenopausal women in Europe who could benefit from this impactful treatment. Our aligned, strategic vision of bringing effective solutions to the right patient gives us unwavering confidence in this partnership. We look forward to seeing the continued global expansion of abaloparatide to patients with osteoporosis worldwide.” - Scott Briggs, CEO of Radius
About Theramex
Theramex is a leading global speciality pharmaceutical company dedicated to women and their health. Theramex supports women at different stages of their lives by providing a broad portfolio of innovative and established brands covering contraception, fertility, menopause, and osteoporosis. Theramex’s commitment is to listen to and understand its patients, serve their needs and offer healthcare solutions to help improve their lives. Theramex’s vision is to be a lifetime partner for women and the healthcare professionals who treat them by providing patient-focused and effective solutions that care for and support women through different stages of their life.
www.theramex.com
About Radius
Radius is a global biopharmaceutical company focused on addressing unmet medical needs in the areas of bone health and oncology. Radius’ lead product, TYMLOS® (abaloparatide) injection, was approved by the U.S. Food and Drug Administration in April 2017 for the treatment of postmenopausal women with osteoporosis at high risk for fracture, and in December 2022 for the treatment of men with osteoporosis at high risk for fracture.
ELADYNOS®(abaloparatide) injection was approved by the European Medicines Agency for the treatment of postmenopausal women with osteoporosis at high risk for fracture defined as history of osteoporotic fracture, multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapies. This medicine is under additional monitoring, meaning that it is monitored even more intensively than other medicines.
www.radiuspharm.com
FOR MEDIA AND INVESTORS ONLY
ELAD_HQ_PRESSR_009443 D.O.P 8/3/23
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230308005585/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Smartstream Further Enables Collateral Teams with Instant Answers and Controlled Automation through New MCP Servers15.9.2026 10:00:00 CEST | Press release
Key Facts Smart Collateral helps financial institutions manage the complete margin and collateral lifecycle, providing the control, visibility and governance required to operate at scale. Teams can now interact with that information in plain language, getting answers on agreements, eligibility, positions, margin calls and interest calculations without navigating multiple screens and reports across separate systems. Workflow actions, including creating or failing movements and issuing margin calls, are opt-in, so each firm decides exactly what an AI assistant is permitted to do. Two Model Context Protocol servers connect any MCP-compatible AI assistant to Smart Collateral: one for operating the platform’s APIs, one read-only over the reporting database. Smartstream, the trusted data solutions provider for leading global financial institutions and enterprises, today announces two new Model Context Protocol (MCP) servers for Smart Collateral, enabling dynamic, agentic collateral operation
More Than Half of Global Businesses Want Greater Control Over Their Data in Latest Digital Sovereignty Push, According to Expereo15.9.2026 10:00:00 CEST | Press release
The findings highlight the growing role of network visibility in digital sovereignty strategies as enterprises navigate increasingly complex cloud, AI and connectivity environments Businesses around the world are seeking greater control over their data as growing concerns around AI, security and compliance push digital sovereignty higher up the boardroom agenda, according to the latest IDC InfoBrief commissioned by Expereo*. More than half (53%) of enterprises say they want greater control over sensitive and strategic data, while 33% of global organizations now view digital sovereignty as a top or high priority. The research also found that 30% rank it among the leading drivers of technology investment, highlighting how governance, risk and compliance considerations are becoming increasingly important as organisations scale AI and cloud initiatives. The findings suggest organizations are looking beyond traditional approaches to data governance as they seek to better manage risk, regula
SES and Elveo Mobile Deepen Collaboration to Advance Direct-to-Device Services in Europe15.9.2026 09:30:00 CEST | Press release
SES, a global leader in space solutions, and Elveo Mobile, the company that delivers mobile connectivity and elevated intelligence for a planet on the move, today announced the expansion of their collaboration to accelerate delivery of direct-to-device (D2D) services in Europe. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260915183604/en/ SES and Elveo Mobile Deepen Collaboration to Advance Direct-to-Device Services in Europe SES will leverage Elveo’s patented, proven and cost-effective D2D technology to enable seamless mobile roaming capabilities for European consumers, businesses, governments, institutional, and defense users. To further this vision, SES and Elveo Mobile will collaborate to establish manufacturing capabilities and a robust supply chain in Europe for the productions of the Low-Earth Orbit (LEO) D2D satellites, using Elveo’s patented D2D satellite bus, payload and software technology stack. These LEO D2D s
Wolters Kluwer expands Libra legal AI workspace with authoritative expert content from Kluwer Law International15.9.2026 09:01:00 CEST | Press release
Leading arbitration, competition and IP law content now available within Libra by Wolters Kluwer, helping legal professionals access specialist expertise directly in their AI-powered workflows Wolters KluwerLegal & Regulatory today announced the integration of Kluwer Law International content into Libra by Wolters Kluwer, its all-in-one legal AI workspace. Customers in 11 European countries can now access content from Kluwer Arbitration, Kluwer Competition Law and Kluwer IP Law directly within Libra, further expanding the platform's portfolio of trusted legal content and expert insight. The addition of Kluwer Law International content builds on Libra's existing legal intelligence capabilities and gives legal professionals access to specialist international expertise across arbitration, competition law and intellectual property law without leaving their workflow. Content can be used alongside the broader Wolters Kluwer legal resources already available within Libra, helping users conduc
Quectel Announces Launch of Tarrius to Deliver Next-Generation Precision Positioning Solutions for Demanding Field Applications15.9.2026 09:00:00 CEST | Press release
Quectel Wireless Solutions, a global end-to-end IoT solutions provider, today announces the launch of Tarrius, a new precision technology solution focused on advancing spatial intelligence. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260915860977/en/ Quectel announces launch of Tarrius to deliver next-generation precision positioning solutions for demanding field applications Operating across APAC, Latin America, EMEA and China, Tarrius combines advanced positioning technology and specialist industry expertise with Quectel’s global engineering, manufacturing, and service capabilities, to deliver dependable, high-accuracy solutions for demanding field applications including surveying and mapping, deformation monitoring and machine guidance. Tarrius combines precision positioning, reliable connectivity and efficient data transmission to enable more accurate, streamlined digital workflows in the field. “Tarrius is built arou
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom